BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25158186)

  • 1. Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth.
    Salmon B; Bardet C; Coyac BR; Baroukh B; Naji J; Rowe PS; Opsahl Vital S; Linglart A; Mckee MD; Chaussain C
    Connect Tissue Res; 2014 Aug; 55 Suppl 1():79-82. PubMed ID: 25158186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia.
    Salmon B; Bardet C; Khaddam M; Naji J; Coyac BR; Baroukh B; Letourneur F; Lesieur J; Decup F; Le Denmat D; Nicoletti A; Poliard A; Rowe PS; Huet E; Vital SO; Linglart A; McKee MD; Chaussain C
    PLoS One; 2013; 8(2):e56749. PubMed ID: 23451077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.
    Coyac BR; Hoac B; Chafey P; Falgayrac G; Slimani L; Rowe PS; Penel G; Linglart A; McKee MD; Chaussain C; Bardet C
    J Dent Res; 2018 Feb; 97(2):184-191. PubMed ID: 28880715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.
    Boukpessi T; Gaucher C; Léger T; Salmon B; Le Faouder J; Willig C; Rowe PS; Garabédian M; Meilhac O; Chaussain C
    Am J Pathol; 2010 Aug; 177(2):803-12. PubMed ID: 20581062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
    Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
    Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage.
    Addison WN; Masica DL; Gray JJ; McKee MD
    J Bone Miner Res; 2010 Apr; 25(4):695-705. PubMed ID: 19775205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
    Rowe PS
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
    Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
    J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
    Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
    J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.
    Addison WN; Nakano Y; Loisel T; Crine P; McKee MD
    J Bone Miner Res; 2008 Oct; 23(10):1638-49. PubMed ID: 18597632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia.
    Boukpessi T; Hoac B; Coyac BR; Leger T; Garcia C; Wicart P; Whyte MP; Glorieux FH; Linglart A; Chaussain C; McKee MD
    Bone; 2017 Feb; 95():151-161. PubMed ID: 27884786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired mineral quality in dentin in X-linked hypophosphatemia.
    Coyac BR; Falgayrac G; Penel G; Schmitt A; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
    Connect Tissue Res; 2018 Dec; 59(sup1):91-96. PubMed ID: 29745817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active sites of human MEPE-ASARM regulating bone matrix mineralization.
    Minamizaki T; Sakurai K; Hayashi I; Toshishige M; Yoshioka H; Kozai K; Yoshiko Y
    Mol Cell Endocrinol; 2020 Nov; 517():110931. PubMed ID: 32712387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).
    Rowe PS; Garrett IR; Schwarz PM; Carnes DL; Lafer EM; Mundy GR; Gutierrez GE
    Bone; 2005 Jan; 36(1):33-46. PubMed ID: 15664000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of odontoblasts is negatively regulated by MEPE via its C-terminal fragment.
    Wang H; Kawashima N; Iwata T; Xu J; Takahashi S; Sugiyama T; Suda H
    Biochem Biophys Res Commun; 2010 Jul; 398(3):406-12. PubMed ID: 20599717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dentin alteration of deciduous teeth in human hypophosphatemic rickets.
    Boukpessi T; Septier D; Bagga S; Garabedian M; Goldberg M; Chaussain-Miller C
    Calcif Tissue Int; 2006 Nov; 79(5):294-300. PubMed ID: 17115324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dentin noncollagenous matrix proteins in familial hypophosphatemic rickets.
    Gaucher C; Boukpessi T; Septier D; Jehan F; Rowe PS; Garabédian M; Goldberg M; Chaussain-Miller C
    Cells Tissues Organs; 2009; 189(1-4):219-23. PubMed ID: 18701809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
    Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
    Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia.
    Hoac B; Østergaard M; Wittig NK; Boukpessi T; Buss DJ; Chaussain C; Birkedal H; Murshed M; McKee MD
    J Bone Miner Res; 2020 Oct; 35(10):2032-2048. PubMed ID: 32501585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.